Sign in

Mel Eckersley-Maslin

@meleckmas.bsky.social
1.2K followers 862 following 59 posts

Lab head in stem cell and cancer epigenetics at PeterMac, UniMelb 🇦🇺🧬 Scientist, mum, dreamer She/her. Views are my own www.eckmaslab.com

PostsRepliesMedia
Reposted by Mel Eckersley-Maslin
Development @dev-journal.bsky.social · 29/09/2026
Pathway to Independence – an interview with Evan Healy In this interview, we learn about @evhealy.bsky.social's career path, what he hopes to gain from the Pathway to Independence programme, and what questions he hopes to tackle with his own group. doi.org/10.1242/dev....
086
Reposted by Mel Eckersley-Maslin
Angelika Feldmann @angelikafeldmann.bsky.social · 18/09/2026
1\ We know a bit about how 3D chromatin interactions are formed, but what do we know about how they are disrupted? We asked this question in our latest preprint: doi.org/10.64898/202..., focusing on the massive loss of promoter interactions during neuronal differentiation.
doi.org
Developmentally programmed loss of long-range Polycomb interactions is regulated by cohesin
Distal regulatory elements (DREs), such as enhancers, can regulate genes across megabase-long distances, presumably via coming into close spatial proximity. The establishment of new transcriptional programmes during cell type transitions is associated with widespread rewiring of the spatial organisation of the genome, including gain and loss of chromatin interactions. Extensive effort has been invested into understanding how chromatin interactions are formed during development, yet the mechanisms underlying their developmental loss remain largely unclear. By leveraging chromatin accessibility-assisted footprinting, acute protein degradation and chromatin conformation capture, we show that loss of promoter interactions cannot be explained by reduced binding of sequence-specific transcription factors (TFs). Instead, we identify a subset of interactions that depend on cohesin for programmed developmental disruption. These sites are characterized by high Polycomb enrichment and TF occupancy and engage in strong long-range interactions that undergo extensive differentiation-dependent rewiring. Preventing interaction loss by acute cohesin degradation results in the preferential downregulation of associated genes. Together, these results suggest that cohesin indirectly regulates developmental loss of Polycomb interactions by enabling the acquisition of other potentially regulatory contacts in a process that may shape transcriptional programs during cell type transitions. ### Competing Interest Statement The authors have declared no competing interest. European Research Council Helmholtz Society, VH-NG-1604
24824
Mel Eckersley-Maslin @meleckmas.bsky.social · 16/09/2026
Sad to hear about Terri’s passing. I have fond memories of her from my graduate student days at CSHL. and am grateful for some rather direct career advice she gave me at the time. My thoughts are with all those close to her. She will be missed
030
Reposted by Mel Eckersley-Maslin
Duncan Sproul @sproullab.bsky.social · 14/09/2026
🚨 #Postdoc position open. Want to understand non-canonical #epigenetic regulation of mammalian transcription? Come work @uoe-igc.bsky.social in Edinburgh! We’re looking for a motivated & collaborative colleague with a strong track record. 📅 14 October 2026 📢 Please share Apply here 👇
elxw.fa.em3.oraclecloud.com
Post-Doctoral Research Associate
An exciting postdoctoral position is available to research the role of epigenetic marks in gene regulation.
01820
Reposted by Mel Eckersley-Maslin
Harmit Singh Malik @harmitmalik.bsky.social · 10/09/2026
Reposting this ongoing search (any discipline of biology) for an Assistant to Associate level colleague in the Division of Basic Sciences at Fred Hutch. Great city, great colleagues, great core facilities, great trainees.
16468
Reposted by Mel Eckersley-Maslin
EMBL Australia @emblaustralia.org · 28/08/2026
Ready to take the next step in your research career? 👨‍🔬 We're seeking an outstanding researcher to establish an independent research program as an EMBL Australia Group Leader at the Australian Regenerative Medicine Institute (ARMI) @monashuniversity.bsky.social 🗓️ Apply by 2 October 🔗 bit.ly/4qHYtjb
0611
Mel Eckersley-Maslin @meleckmas.bsky.social · 25/08/2026
Had a great time visiting @vonmeyenn.bsky.social at ETH Zürich yesterday and sharing some of the labs latest work. Thanks for the invite, lively discussions and good food! Next stop Heidelberg for the #EMBLTranscript meeting that starts later today
0142
Mel Eckersley-Maslin @meleckmas.bsky.social · 21/08/2026
Our lab had an international brunch where everyone brought in something from their culture to share. They even printed out little place-cards with flags and ingredients. So much delicious food!
060
Mel Eckersley-Maslin @meleckmas.bsky.social · 20/08/2026
Preprint from Katerina Gurova's group looking at oncogenic competency. Using barcoding and scRNAseq, suggest all cells respond to oncogenic insults, yet only some stabilise as transformed. Explores many of the concepts we regularly discuss in the lab. www.biorxiv.org/content/10.6...
biorxiv.org
011
Mel Eckersley-Maslin @meleckmas.bsky.social · 03/08/2026
Latest from @arnaudkr.bsky.social on TF cooperation at enhancers, liked the combination of single-molecule footprinting at ectopic vs endogenous loci in mESCs. Curious if the cumulative activation frequency model holds for other less proliferative/plastic cell types? www.nature.com/articles/s41...
nature.com
Cumulative transcription factor binding and p300-mediated histone acetylation drive enhancer activation frequency - Nature Genetics
This study uses single-molecule footprinting to quantify chromatin accessibility at enhancers and promoters in mouse embryonic stem cells and to dissect the contributions of transcription factor bindi...
2329
Mel Eckersley-Maslin @meleckmas.bsky.social · 31/07/2026
Agreed, and I really like the model, just trying to wrap my head around how it works molecularly. It reminds me a bit of the FLC locus in Arabidopsis and wonder if any of those concepts might apply here
010
Mel Eckersley-Maslin @meleckmas.bsky.social · 30/07/2026
Intestinal stem cells count divisions and Polycomb/trithorax proteins are involved in the counting, implicating chromatin control. Love the model but would be great to know if it’s truely counting and not time, and how mechanistically replication dilution of histone mods ensures 9 cell cycles?
1110
Mel Eckersley-Maslin @meleckmas.bsky.social · 29/07/2026
Congrats on the study! Curious if there’s a way to speed up figuring out the effect of all the variants? It’s a big challenge for VUS
100
Reposted by Mel Eckersley-Maslin
ARC Tracker @arc-tracker.bsky.social · 22/07/2026
The ARC has released their new set of grant schemes ▶️ www.arc.gov.au/news-and-pub... Before implementing them, they’re now going to “consult with the sector”. Hopefully genuinely, not just with a few disengaged DVCRs. In the meantime, there’ll be another round of Discovery Projects (DP28).
arc.gov.au
32620
Reposted by Mel Eckersley-Maslin
Paul Francois @pfrancois.bsky.social · 14/07/2026
New paper 🧵 What if the "landscape" that guides cell differentiation isn't fixed, but is sculpted, in real time, by the very cells moving through it? We call this a 'sandscape' : grains of sand that carve dunes as they move, while the dunes' shape simultaneously steers where the grains go next.
37938
Reposted by Mel Eckersley-Maslin
Alex Radzisheuskaya @a-radzisheuskaya.bsky.social · 08/07/2026
1/ Very excited to share the first publication from my lab! In this work, we developed an efficient strategy to precisely mutate mammalian histone genes in their native genomic context using CRISPR prime editing: www.nature.com/articles/s41...
nature.com
Identifying critical lysines in mammalian histone H3 with high-throughput CRISPR prime editing - Nature Genetics
This study uses a precise and efficient clustered regularly interspaced short palindromic repeats (CRISPR) prime editing system to substitute lysine residues in histone H3, individually or in combinat...
1112044
Reposted by Mel Eckersley-Maslin
FragileNucleosome @fnucleosome.bsky.social · 17/06/2026
We just started our summer break, but we're also planning our September-December seminar schedule! If you have an exciting chromatin/transcription story that will be ready for the spotlight by then, use the survey below to nominate yourself to give a #FNucleosome talk 🧬🧬 forms.gle/1EKYN2Nt79ar...
forms.gle
Application to speak in the Fragile Nucleosome series
Thank you for your interest in our seminar series! We use a variety of different session formats but, in general, trainees can plan for a ~15 min talk + 5min Q/A and PIs can plan for a ~25min talk +...
01011
Reposted by Mel Eckersley-Maslin
GOA - Genome Organisation Australia @genome-org-aus.bsky.social · 11/06/2026
Please join us for the next edition of the GOA monthly seminar series Dr Karissa Hansen Registration link: unimelb.zoom.us/webinar/regi...
144
Reposted by Mel Eckersley-Maslin
Mark Ziemann 🇺🇦🌻🦩 @mdziemann.genomic.social.ap.brid.gy · 10/06/2026
If you're in Melbourne and interested in genomics and epigenetics, come along to the #Melbourne #Epigenetics club 4pm today. Visit the website to get club email updates: www.eckmaslab.com/melbourne-epigene…
Seminar poster featuring Nir Eynon, Natasha Jansz and William Hamilton. Hosted at Melbourne Uni 10th June
023
Reposted by Mel Eckersley-Maslin
Mikhail Spivakov @mspivakov.bsky.social · 08/06/2026
Our story about the poising and connectivity of human developmental enhancers is out! www.cell.com/cell-reports...
1197
Reposted by Mel Eckersley-Maslin
Lara Krüger @lara-kruger.bsky.social · 09/06/2026
📢 We are looking for a Junior Group Leader to join us at @institutcurie.bsky.social! Having joined the department just over a year ago, I can honestly say that it is an exceptionally stimulating and supportive scientific environment, filled with outstanding colleagues — all in the heart of Paris.
19698
Reposted by Mel Eckersley-Maslin
Dan Landau @landau.bsky.social · 04/06/2026
Exciting breakthrough technology from the lab, now live in @cellcellpress.bsky.social ! Instead of cutting the genome where proteins bind (e.g., Cut&Tag), D&D-seq scars the DNA with a deaminase, allowing single cell genome mapping of TFs and chromatin remodellers!
212851
Reposted by Mel Eckersley-Maslin
Reese Richardson @reeserichardson.bsky.social · 28/05/2026
TL;DR: We've identified more than 100 cases of apparent manipulation in Thermo Fisher Scientific's antibody verification data. @sholtodavid.bsky.social @johanduchene.bsky.social reeserichardson.blog/2026/05/28/h...
reeserichardson.blog
How much of Thermo Fisher’s antibody data has been manipulated?
We’ve documented more than 100 instances of apparent data manipulation in Thermo’s catalog
23591312
Mel Eckersley-Maslin @meleckmas.bsky.social · 08/05/2026
You can now read this in the latest issue of @genesdev.bsky.social. It should be open access, but please reach out if you need an access code genesdev.cshlp.org/content/40/9...
genesdev.cshlp.org
Embryonic stem cell factors DPPA2/4 amplify active H3K4me3–H2AK119ub chromatin domains in non-small cell lung cancer
A biweekly scientific journal publishing high-quality research in molecular biology and genetics, cancer biology, biochemistry, and related fields
060
Reposted by Mel Eckersley-Maslin
Genes & Development @genesdev.bsky.social · 23/04/2026
🆕 ADVANCE ONLINE 🆕 RESEARCH PAPER: Embryonic stem cell factors DPPA2/4 amplify active H3K4me3–H2AK119ub chromatin domains in non-small cell lung cancer By Seneviratne et al. and Melanie A. Eckersley-Maslin ➡️ ow.ly/ybJl50YNzz0 Mel Eckersley-Maslin Peter MacCallum Cancer Centre #lungcancer
041
Reposted by Mel Eckersley-Maslin
GOA - Genome Organisation Australia @genome-org-aus.bsky.social · 08/04/2026
Please join us for the next edition of the GOA monthly seminar series A/Prof. R. Babak Faryabi @faryabi.bsky.social! Registration link: unimelb.zoom.us/webinar/regi...
023
Reposted by Mel Eckersley-Maslin
Australasian Epigenetic Alliance (AEpiA) @aepia.bsky.social · 31/03/2026
𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 𝗮𝗿𝗲 𝗻𝗼𝘄 𝗼𝗽𝗲𝗻 𝗳𝗼𝗿 𝘁𝗵𝗲: 𝗔𝗘𝗽𝗶𝗔 𝗦𝘂𝘀𝗮𝗻 𝗖𝗹𝗮𝗿𝗸 𝗔𝘄𝗮𝗿𝗱 𝗳𝗼𝗿 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗘𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝗰𝗲 @aepia.bsky.social is excited to open applications for the Susan Clark Award for Research Excellence, recognising outstanding contributions in epigenetics research, leadership, and advocacy.
112
Reposted by Mel Eckersley-Maslin
Michela Palamin @mpalamin.bsky.social · 24/03/2026
ChromSMF preprint is out!🚀 tinyurl.com/ChromSMF We often piece together chromatin regulation layer by layer from separate assays. But this can be limiting! In @arnaudkr.bsky.social's lab, we developed a method to directly study multiple layers on the same DNA molecule! 🧬 What does this unlock? ⬇️
311551
Reposted by Mel Eckersley-Maslin
Peter MacCallum Cancer Centre @petermaccc.bsky.social · 22/03/2026
𝗢𝘂𝘁 𝘁𝗼𝗱𝗮𝘆: Research at Peter Mac led by @meleckmas.bsky.social has uncovered a surprising driver behind aggressive lung cancer — embryonic proteins that are normally only active before birth. Read more: www.petermac.org/about-us/new... #LungCancerResearch #LungCancer
033
Mel Eckersley-Maslin @meleckmas.bsky.social · 22/03/2026
We propose DPPA2/4 act as chromatin amplifiers in a context dependent manner. In embryonic stem cells they amplify bivalent H3K4me3-H3K27me3 chromatin, while in lung cancer cells they alter H2AK119ub and H3K27ac. Thanks to all who contributed to the study! (8/8) genesdev.cshlp.org/content/earl...
Model describing how DPPA2/4 amplify active chromatin states. Full paper can be accessed here https://genesdev.cshlp.org/content/early/2026/03/18/gad.353102.125.full.pdf+html
030
Mel Eckersley-Maslin @meleckmas.bsky.social · 22/03/2026
If we introduce DPPA2/4 in non-small cell lung cancer cells where it's not usually expressed, it binds active CpG rich regions. Here it changes the chromatin states at over half its binding sites to a more active state (as determined by ChromHMM) (7/8)
100
Mel Eckersley-Maslin @meleckmas.bsky.social · 22/03/2026
What happens if DPPA2/4 is removed? Surprisingly, the classic bivalent marks it regulates in stem cells (H3K4me3 and H3K27me3) are unaltered. Neither is transcription or chromatin accessibility. Instead we see a loss of H2AK119ub at these unique active sites (6/8)
120
Mel Eckersley-Maslin @meleckmas.bsky.social · 22/03/2026
PRC2 is at these sites, but not it's product H3K27me3. We noticed H3K27ac was also there so hypothesised it might be blocking PRC2 activity. However removing H3K27ac (using A-485), at least for 24hrs, did not lead to an increase in H3K27me3 (5/8)
110
Mel Eckersley-Maslin @meleckmas.bsky.social · 22/03/2026
Interesting, some of these DPPA2/4 bound active regions had PRC1-deposited H2AK119ub but not PRC2-deposited H3K27me3. We applied our reChIP protocol (link.springer.com/article/10.1...) to confirm co-occurrence of H2AK119ub with H3K4me3, and rule out cellular heterogeneity. (4/8)
100
Mel Eckersley-Maslin @meleckmas.bsky.social · 22/03/2026
Chromatin profiling in lung cancer cells that endogenously express DPPA2/4 revealed they like to bind open CpG rich regions of the genome. This is similar to their binding profiles in embryonic stem cells (see www.nature.com/articles/s41... and others) (3/8)
110
Mel Eckersley-Maslin @meleckmas.bsky.social · 22/03/2026
Co-expression of Developmental Pluripotency Associated 2 and 4 (DPPA2/4) is linked with worse survival, in particular for non-small cell lung cancer. So we generated a series of knockdown, over-expression and knockout cell models to understand molecularly why this is (2/8)
plot showing survival of different cohorts of cancer patients that co-express DPPA2/4
100
Mel Eckersley-Maslin @meleckmas.bsky.social · 22/03/2026
Delighted to share the lab's latest led by superstar Janith and funded by @snowmedical.bsky.social. What happens when embryonic factors are reawakened in cancers? We uncovered how DPPA2/4 amplify chromatin states in non-small cell lung cancer 🧬🔬🧪 genesdev.cshlp.org/content/earl... Tutorial 👇 (1/8)
genesdev.cshlp.org
Embryonic stem cell factors DPPA2/4 amplify active H3K4me3–H2AK119ub chromatin domains in non-small cell lung cancer
A biweekly scientific journal publishing high-quality research in molecular biology and genetics, cancer biology, biochemistry, and related fields
13115
Reposted by Mel Eckersley-Maslin
Charlène Boumendil (She/Her) @charleneboumendil.bsky.social · 20/03/2026
We are looking for a new group leader to join the IGH (Montpellier, France). I can’t wait to meet my future colleague! Apply :-) More infos here: igh.cnrs.fr/join-igh-as-...
igh.cnrs.fr
Join IGH as Group Leader - IGH
The Institute of Human Genetics invites applications for a Principal Investigator position in its main research areas. Read more...
05262
Reposted by Mel Eckersley-Maslin
Netherlands Cancer Institute @nkinl.bsky.social · 20/02/2026
We;re hiring Junior Group Leaders! 🔬✨ We’re looking for researchers in immunology, chemical biology, AI in biology, or protein design to launch their own independent groups in our collaborative, international environment. www.nki.nl/news-events/...
01829
Reposted by Mel Eckersley-Maslin
The EMBO Journal @embojournal.org · 17/03/2026
Eliminating the confounding effects of human pluripotent #stemcell co-culture with MEFs: @grazianomartello.bsky.social @leeboratory.bsky.social @jzylicz.bsky.social and collaborators describe a serum coating approach for feeder-free culture of naïve hPSCs link.springer.com/article/10.1...
link.springer.com
Serum coating enables feeder-free culture of naive human pluripotent stem cells preserving developmental potential - The EMBO Journal
Naive human pluripotent stem cells (hPSCs) represent a pre-implantation epiblast state able to efficiently differentiate into embryonic and extraembryonic pre-implantation lineages and to self-organis...
01611
Reposted by Mel Eckersley-Maslin
Elzo de Wit lab @ NKI @dewitlab.bsky.social · 18/03/2026
🧵 CTCF is essential for embryonic development, but why has remained unclear. By combining gastruloids with a temporal degron system, we uncovered a surprising dual function — and it changes how we think about CTCF's role in development. 1/8 www.biorxiv.org/content/10.6...
biorxiv.org
A dual role for CTCF in development
CTCF is an essential DNA binding protein whose absence leads to embryonic lethality. CTCF is primarily known for its role in 3D genome organization where its N-terminal domain interacts with cohesin to anchor chromatin loops. How CTCF facilitates proper embryonic development remains unclear, necessitating temporal control to resolve its stage-specific functions. By combining gastruloids, an in vitro model of embryonic development, with a degron system to rapidly deplete CTCF at defined timepoints, we show that early CTCF depletion impairs early gastruloid morphogenesis. Surprisingly, ATAC-seq and time-resolved RNA-seq revealed that differentiation was unaffected. CTCF binding is strongly enriched at promoters of downregulated genes. Re-expression of a CTCF variant with an N-terminal truncation, incapable of looping, was sufficient to rescue the expression of CTCF-promoter bound genes and the defects in morphogenesis. However, extended culture (up to 168 hours) of gastruloids reconstituted with N-terminal truncated CTCF led to their collapse. Our work shows that CTCF has a dual function in early mammalian development: at early stages CTCF regulates developmentally important genes through promoter binding, while at later stages its looping function is required for correct development. ### Competing Interest Statement The authors have declared no competing interest. European Research Council, https://ror.org/0472cxd90, 637587, 865459 Dutch Research Council, https://ror.org/04jsz6e67, 016.161.316, VI.C.222.049 Dutch Cancer Society, https://ror.org/0368jnd28, N/A
711455
Reposted by Mel Eckersley-Maslin
Rob Klose @robklose.bsky.social · 13/03/2026
We are excited to be recruiting into 3 Associate Professorship's in @oxfordbiochemistry.bsky.social. Come join us as a colleague and benefit from our vibrant and multidisciplinary environment. Reach out to me if you have any questions. Please repost! (tinyurl.com/48deybuu) (tinyurl.com/4pdvjaft).
1106125
Reposted by Mel Eckersley-Maslin
Maxim Greenberg @maxvcg.bsky.social · 09/03/2026
Very excited to announce the FIRST symposium on epigenome editing! These tools are becoming widely used in mol bio, ag & therapy. It's time to bring leaders together to discuss this rapidly growing and exciting field. And why not in Paris! Please register & share! (1/2) ctrlepiedit.sciencesconf.org
Flyer for symposium: https://ctrlepiedit.sciencesconf.org/
38758
Reposted by Mel Eckersley-Maslin
Dr Monique Ryan @mon4kooyong.bsky.social · 09/03/2026
More than 60% of Australian medical researchers left active research roles between 2019 & 2024 because they could not make ends meet - while my costings from the PBO suggest the govt could more than double annual spending from the MRFF without any effect on its base level of funding.
abc.net.au
Up to $1.4 billion in medical research remains unused under government cap
Researchers say securing funding has become increasingly tough, with many left with no choice but to spend a disproportionate amount of time applying for grants.
514754
Reposted by Mel Eckersley-Maslin
Chen Davidovich @davidovichlab.bsky.social · 04/03/2026
1/ 🧵 In our new paper, we show that JARID2 and PALI1 mimic H3K27me3 to antagonise PRC2. www.cell.com/molecular-ce...
cell.com
Accessory subunits of PRC2 mimic H3K27me3 to restrict the spread of Polycomb domains
Some proteins mimic the repressive mark H3K27me3, but the physiological relevance of this phenomenon was unclear. Agius et al. show that the PRC2 subunits JARID2 and PALI1 mimic H3K27me3 to antagonize...
16025
Reposted by Mel Eckersley-Maslin
Maria Alcolea @mariapalcolea.bsky.social · 04/03/2026
🚨 New paper from our lab just published in Nature🚨 www.nature.com/articles/s41... Discover how 🌱 tumour formation is shaped by tissue context from the very beginning. Cancer is not driven by genetics alone ✨Fantastic team led by Greta Skrupskelyte, Eduardo Rojo, @hariajith.bsky.social
911440
Mel Eckersley-Maslin @meleckmas.bsky.social · 03/03/2026
Try spinning down your antibodies before using. You can also add some tween to your wash buffers
120
Mel Eckersley-Maslin @meleckmas.bsky.social · 03/03/2026
Frustrated I can’t be in person at #KSEpigenetics26. Unfortunately I couldn’t travel to Geneva from Australia due to the conflict in the Middle East. Hoping everyone has a great conference and I’ll be able to join in person next time!
040
Reposted by Mel Eckersley-Maslin
Takeshi Uenaka @tuenaka.bsky.social · 19/02/2026
Losing sleep over #iPSC transgene silencing after differentiation? Same here. Bright in iPSCs. Gone after differentiation. Our paper in @cp-cellstemcell.bsky.social maps what actually keeps expression on👇 www.cell.com/cell-stem-ce... 🔗 Free access (50 days): www.sciencedirect.com/science/auth...
sciencedirect.com
Please wait whilst we redirect you
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
11311